<?xml version="1.0" encoding="UTF-8"?>
<p id="Par20">Since SARS-CoV-2 and SARS-CoV share the receptor ACE2 and their RBDs have similar sequences, the NMAbs against SARS-CoV-2 can be classified in the same way as those against SARS-CoV (Fig. 
 <xref rid="Fig4" ref-type="fig">4</xref>).
</p>
